Amyloidosis

We recommend

Stabilization of Transthyretin and Long-term Survival of Patients with Cardiac Amyloidosis

20. 11. 2023 Source: Amyloidosis

Tafamidis is used in the therapy of transthyretin amyloid cardiomyopathy (ATTR-CM), which has proven its benefit in the ATTR-ACT clinical study. The results of its open-label extension study show that early diagnosis and prompt initiation of therapy are crucial.

Transthyretin Amyloidosis in Patients with Carpal Tunnel Syndrome

Carpal tunnel syndrome is considered a warning sign for cardiac amyloidosis. Amyloid deposits are…

10. 11. 2023 Source: Amyloidosis

Which biomarkers can be used for risk stratification in ATTR cardiac amyloidosis?

Effective treatment for patients with transthyretin cardiac amyloidosis requires timely diagnosis…

11. 7. 2023 Source: Amyloidosis

Articles on this topic

When You Say Amyloid…

The term 'amyloid' was first used by the German doctor Rudolf Virchow in the mid-19th century.…

12. 12. 2022 Source: Amyloidosis

Autonomic Dysfunction in Patients with Transthyretin Amyloidosis

Autonomic nervous system disorders are a common complication of transthyretin amyloidosis.…

12. 7. 2022 Source: Amyloidosis

Journal articles Involvement of the gastrointestinal tract in amyloidosis: when to think about it and how to diagnose

Amyloidózy jsou onemocnění odlišné etiologie, u kterých dochází k depozici abnormálně uspořádaných...

23. 4. 2019 Source: Gastroenterology and Hepatology | 2/2019

Journal articles Hereditary amyloidosis – aetiology, clinical features and treatment options

Amyloidózy tvoří různorodou skupinu onemocnění charakterizovanou tvorbou patologického bílkovinného...

5. 12. 2015 Source: Transfusion and Haematology Today | 4/2015

1 2

E-courses on this topic

Authors: MUDr. Radim Mazanec, Ph.D.

Course detail